# VALGANCICLOVIR HYDROCHLORIDE
> **ANDA209672** · Abbreviated New Drug Application (Generic) · Sponsor: CIPLA · Approved 2018-11-09
## Drug
- **FDA Application Number:** ANDA209672
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** VALGANCICLOVIR HYDROCHLORIDE
- **Generic name:** Valganciclovir Hydrochloride
- **Active ingredients:** VALGANCICLOVIR HYDROCHLORIDE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** CIPLA
- **First approval:** 2018-11-09
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209672)
---
*MORVS · CC0 1.0*